Anti-CD8 monoclonal antibody

Drug Profile

Anti-CD8 monoclonal antibody

Alternative Names: Anti-CD8; Anti-Leu-2; Anti-Ly-2.1

Latest Information Update: 13 Feb 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Becton, Dickinson and Company
  • Class Antiretrovirals; Monoclonal antibodies
  • Mechanism of Action CD8 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Graft-versus-host disease; Transplant rejection

Most Recent Events

  • 19 Oct 1998 A preclinical study has been added to the pharmacodynamics section
  • 04 Apr 1996 A preclinical study has been added to the pharmacodynamics section
  • 15 Jan 1995 Investigation in Graft-versus-host disease in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top